501 related articles for article (PubMed ID: 28170111)
21. Sleep correlates of trait executive function and memory in Parkinson's disease.
Scullin MK; Fairley JA; Trotti LM; Goldstein FC; Factor SA; Bliwise DL
J Parkinsons Dis; 2015; 5(1):49-54. PubMed ID: 25588355
[TBL] [Abstract][Full Text] [Related]
22. Cognitive functioning in individuals with Parkinson's disease and traumatic brain injury: A longitudinal study.
Schiehser DM; Filoteo JV; Litvan I; Pirogovsky-Turk E; Lessig SL; Song DS
Parkinsonism Relat Disord; 2016 Sep; 30():58-61. PubMed ID: 27260791
[TBL] [Abstract][Full Text] [Related]
23. The Multiple Object Test as a Performance Based Tool to Assess Cognitive Driven Activity of Daily Living Function in Parkinson's Disease.
Glonnegger H; Beyle A; Cerff B; Gräber S; Csoti I; Berg D; Liepelt-Scarfone I
J Alzheimers Dis; 2016 Jul; 53(4):1475-84. PubMed ID: 27392856
[TBL] [Abstract][Full Text] [Related]
24. Awareness of executive deficits in people with Parkinson's disease.
Kudlicka A; Clare L; Hindle JV
J Int Neuropsychol Soc; 2013 May; 19(5):559-70. PubMed ID: 23410890
[TBL] [Abstract][Full Text] [Related]
25. Freezing of gait subtypes have different cognitive correlates in Parkinson's disease.
Factor SA; Scullin MK; Sollinger AB; Land JO; Wood-Siverio C; Zanders L; Freeman A; Bliwise DL; Goldstein FC
Parkinsonism Relat Disord; 2014 Dec; 20(12):1359-64. PubMed ID: 25446341
[TBL] [Abstract][Full Text] [Related]
26. [Cognitive reserve questionnaire. Scores obtained in a healthy elderly population and in one with Alzheimer's disease].
Rami L; Valls-Pedret C; Bartrés-Faz D; Caprile C; Solé-Padullés C; Castellvi M; Olives J; Bosch B; Molinuevo JL
Rev Neurol; 2011 Feb; 52(4):195-201. PubMed ID: 21312165
[TBL] [Abstract][Full Text] [Related]
27. Catechol-O-methyltransferase Val158Met polymorphism influences prefrontal executive function in early Parkinson's disease.
Zhang Y; Feng S; Nie K; Zhao X; Gan R; Wang L; Zhao J; Tang H; Gao L; Zhu R; Wang L; Zhang Y
J Neurol Sci; 2016 Oct; 369():347-353. PubMed ID: 27653922
[TBL] [Abstract][Full Text] [Related]
28. Predictors of cognitive and psychosocial outcome after STN DBS in Parkinson's Disease.
Smeding HM; Speelman JD; Huizenga HM; Schuurman PR; Schmand B
J Neurol Neurosurg Psychiatry; 2011 Jul; 82(7):754-60. PubMed ID: 19465417
[TBL] [Abstract][Full Text] [Related]
29. Olfactory performance acts as a cognitive reserve in non-demented patients with Parkinson's disease.
Lee JE; Cho KH; Ham JH; Song SK; Sohn YH; Lee PH
Parkinsonism Relat Disord; 2014 Feb; 20(2):186-91. PubMed ID: 24262869
[TBL] [Abstract][Full Text] [Related]
30. Cognitive reserve and β-amyloid pathology in Parkinson disease.
Lucero C; Campbell MC; Flores H; Maiti B; Perlmutter JS; Foster ER
Parkinsonism Relat Disord; 2015 Aug; 21(8):899-904. PubMed ID: 26037458
[TBL] [Abstract][Full Text] [Related]
31. An active lifestyle is associated with better neurocognitive functioning in adults living with HIV infection.
Fazeli PL; Woods SP; Heaton RK; Umlauf A; Gouaux B; Rosario D; Moore RC; Grant I; Moore DJ;
J Neurovirol; 2014 Jun; 20(3):233-42. PubMed ID: 24554483
[TBL] [Abstract][Full Text] [Related]
32. Impact of specific executive functions on driving performance in people with Parkinson's disease.
Ranchet M; Paire-Ficout L; Uc EY; Bonnard A; Sornette D; Broussolle E
Mov Disord; 2013 Dec; 28(14):1941-8. PubMed ID: 24114952
[TBL] [Abstract][Full Text] [Related]
33. Cognitive impairment in Parkinson's disease: impact on quality of life of carers.
Lawson RA; Yarnall AJ; Johnston F; Duncan GW; Khoo TK; Collerton D; Taylor JP; Burn DJ;
Int J Geriatr Psychiatry; 2017 Dec; 32(12):1362-1370. PubMed ID: 27925292
[TBL] [Abstract][Full Text] [Related]
34. Everyday functioning of people with Parkinson's disease and impairments in executive function: a qualitative investigation.
Kudlicka A; Hindle JV; Spencer LE; Clare L
Disabil Rehabil; 2018 Oct; 40(20):2351-2363. PubMed ID: 28597694
[TBL] [Abstract][Full Text] [Related]
35. Sensitive measures of executive dysfunction in non-demented Parkinson's disease.
Bott NT; Johnson ET; Schuff N; Galifianakis N; Subas T; Pollock J; Pressman P; Kramer JH; Possin KL
Parkinsonism Relat Disord; 2014 Dec; 20(12):1430-3. PubMed ID: 25454318
[TBL] [Abstract][Full Text] [Related]
36. Longitudinal assessment of the pattern of cognitive decline in non-demented patients with advanced Parkinson's disease.
Gasca-Salas C; Estanga A; Clavero P; Aguilar-Palacio I; González-Redondo R; Obeso JA; Rodríguez-Oroz MC
J Parkinsons Dis; 2014; 4(4):677-86. PubMed ID: 25208730
[TBL] [Abstract][Full Text] [Related]
37. Risk factors for executive dysfunction after subthalamic nucleus stimulation in Parkinson's disease.
Daniels C; Krack P; Volkmann J; Pinsker MO; Krause M; Tronnier V; Kloss M; Schnitzler A; Wojtecki L; Bötzel K; Danek A; Hilker R; Sturm V; Kupsch A; Karner E; Deuschl G; Witt K
Mov Disord; 2010 Aug; 25(11):1583-9. PubMed ID: 20589868
[TBL] [Abstract][Full Text] [Related]
38. The Body Position Spatial Task, a Test of Whole-Body Spatial Cognition: Comparison Between Adults With and Without Parkinson Disease.
Battisto J; Echt KV; Wolf SL; Weiss P; Hackney ME
Neurorehabil Neural Repair; 2018 Nov; 32(11):961-975. PubMed ID: 30317924
[TBL] [Abstract][Full Text] [Related]
39. Plasma levels of soluble tumor necrosis factor receptors are associated with cognitive performance in Parkinson's disease.
Rocha NP; Teixeira AL; Scalzo PL; Barbosa IG; de Sousa MS; Morato IB; Vieira EL; Christo PP; Palotás A; Reis HJ
Mov Disord; 2014 Apr; 29(4):527-31. PubMed ID: 24301904
[TBL] [Abstract][Full Text] [Related]
40. Progression of Cognitive Decline in Parkinson's Disease.
Roheger M; Kalbe E; Liepelt-Scarfone I
J Parkinsons Dis; 2018; 8(2):183-193. PubMed ID: 29914040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
